Episodes
Friday Aug 05, 2022
Managing Pain in Patients with High Blood Pressure: Is There No Safe PATH?
Friday Aug 05, 2022
Friday Aug 05, 2022
Pain and hypertension are two of the most prevalent conditions worldwide. Acetaminophen is often considered the “go-to” and the “safe” over-the-counter analgesic for patients with hypertension because it is not commonly believed to increase blood pressure or cardiovascular events. But is that assumption grounded in evidence?
Guest Authors: Lizzie Baumeister, PharmD and Austin Morgan, PharmD, BCACP, CDCES
Music by Good Talk
Tuesday Aug 02, 2022
Tuesday Aug 02, 2022
This episode is a collaboration between the ACCP Ambulatory Care Practice and Research Network (PRN) ... and iForumRx.org.
Wondering if a continuous glucose monitor (CGM) is right for your patient? Worried about workflow, prior authorization, billing, and payment? Our expert panelists explain how they manage patients in their practices and how they bill for their services.
Guests: Jennifer Trujillo, PharmD, BCPS, CDCES, BC-ADM; Edward Saito, PharmD, BCACP; and Christina Sherrill, PharmD, BCACP, CPP
Produced by Jonathan Hughes, PharmD, BCPS, BCACP and Anna Love, PharmD, BCACP
Music by lemonmusicstudio from Pixabay
Tuesday Jul 26, 2022
A Healthier Way to Commute? Cycling Reduces Mortality in Patients with Diabetes
Tuesday Jul 26, 2022
Tuesday Jul 26, 2022
Physical activity is critical to preventing and treating diabetes and reduces cardiovascular disease (CVD) and mortality. Although moderate-to-high intensity aerobic exercise of any type is likely beneficial, cycling is particularly attractive because it is a low-impact exercise (e.g. easier on the joints) and can potentially be used as a transportation method.
Guest Author: Kristin Lutek, PharmD, BCACP, CDCES
Special Guest: Seena L. Haines, PharmD, BCACP, NBC-HWC
Music by Good Talk
Friday Jul 08, 2022
Annual Wellness Visits: Pharmacists Closing Care Gaps
Friday Jul 08, 2022
Friday Jul 08, 2022
Many older adults do not receive recommended screening exams or treatments and frequently take multiple medications that place them at high risk of adverse effects and drug-drug interactions. Pharmacists performing an Annual Wellness Visit (AWV) provides an opportunity to conduct a comprehensive medication review to identify and correct medication-related problems as well as close care gaps.
Guest Authors: Brenna Gelen, PharmD and Nicole Slater, PharmD, BCACP
Music by Good Talk
Tuesday Jun 28, 2022
FOMO — Keeping Up With the Primary Literature
Tuesday Jun 28, 2022
Tuesday Jun 28, 2022
This episode is a collaboration between the ACCP Ambulatory Care Practice and Research Network (PRN) ... and iForumRx.org.
Do you experience FOMO (aka fear of missing out) when it comes to the primary literature? How can you keep on top of the never-ending stream of new evidence that's published (and presented) every day! Of course, iForumRx is one way to keep abreast of the latest evidence ... but there are lots of great tools out there! Our guests share with us their favorite tools for keeping up.
Guests: Greg Castelli, PharmD, BCPS and Kate Cozart, PharmD, BCACP, BCPS, BCGP
Produced by Jonathan Hughes, PharmD, BCPS, BCACP and Anna Love, PharmD, BCACP
Music by lemonmusicstudio from Pixabay
Friday Jun 17, 2022
Friday Jun 17, 2022
The thrombotic antiphospholipid syndrome (TAPS) is associated with atypical thromboembolic events and/or recurrent pregnancy loss. Patients with TAPS are at very high risk of recurrent thrombotic events and require indefinite therapy. Warfarin therapy is very challenging to manage in this patient population and requires frequent monitoring. Thus a direct oral anticoagulant would be a welcomed alternative to warfarin by many patients with TAPS. But are they effective?
Guest Authors: Leslie Walters, PharmD, BCACP and Jennifer Carie, PharmD, BCACP, BC-ADM
Music by Good Talk
Wednesday Jun 08, 2022
The Top Ten Things Every Clinician Should Know About Sacubitril/Valsartan
Wednesday Jun 08, 2022
Wednesday Jun 08, 2022
Sacubitril/valsartan is considered part of the backbone of guideline-recommended therapies for the management of patients with heart failure. In 2021, sacubitril/valsartan became the preferred treatment over an ACEi or ARB in patients with heart failure with reduced ejection fraction (HFrEF) because it reduces the risk of cardiovascular death and hospitalization for heart failure in nearly all adult patients with chronic heart failure. All clinicians should be familiar with the indications, dosing, safety, and monitoring of sacubitril/valsartan. Affordability, access, and inappropriate dose titration remain major barriers to achieving optimal outcomes.
Guest Authors: Jessica Wooster, PharmD, BCACP and Elizabeth Yett, PharmD, BCACP
Special Guest: Dustin (DJ) Clark, PharmD, BCACP
Music by: Good Talk
Friday May 20, 2022
Friday May 20, 2022
Unfortunately, many patients with CAD do not receive the influenza vaccine every year. And many patients being discharged from hospital after an acute coronary event don't receive it either. The IAMI (Influenza Vaccination After Myocardial Infarction) study was the first, large, randomized, double-blind, placebo-controlled, multi-center trial to investigate whether influenza vaccination could reduce the rate of cardiovascular events in high-risk adults with CAD.
Guest Authors: Noelle Cordova, PharmD and Laura McAuliffe, PharmD, BCACP, CDCES
Music by Good Talk
Friday May 06, 2022
Friday May 06, 2022
Two novel oral antiviral agents were granted emergency use authorization (EUA) by the U.S. Food and Drug Administration (FDA) for the treatment of mild to moderate COVID-19 in late December 2021. Although it is named after Thor’s hammer, Mjölnir, molnupiravir was given a last place (4th line) recommendation by the National Institutes of Health (NIH) COVID-19 Treatment Guideline Panel. What gives?
Guest Authors: Amanda Applegate, PharmD, BCACP and Mary Beth Dameron, PharmD, BCACP
Music by Good Talk
Thursday Apr 21, 2022
Thursday Apr 21, 2022
Published in Diabetes Care every January, the Standards of Medical Care in Diabetes by the American Diabetes Association (ADA) provides recommendations for the care of patients with diabetes. And every year clinicians eagerly read, discuss, and apply them in their practices. In this episode, we discuss some of the highlights.
Guest Author: Jennifer N. Clements, PharmD, BCPS, BCACP, CDCES, BC-ADM
Special Guest: Joshua Neumiller, PharmD, CDCES
Music by Good Talk